# Stepan Co: Form 10-Q for the period ended Jun 30, 2017

- Company: [Stepan Co](/companies/scl.md) (CIK 94049)
- Form: 10-Q
- Filed: 2017-07-28
- Accepted by EDGAR: Jul 28, 2017, 12:26 ET
- Period: 2017-06-30
- Accession: 0001564590-17-014350
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/94049/000156459017014350/scl-10q_20170630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/94049/000156459017014350/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-04-01 to 2017-06-30 | $405.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2017-01-01 to 2017-06-30 | $781.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2017-04-01 to 2017-06-30 | $90.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2017-01-01 to 2017-06-30 | $182.1m | us-gaap:GrossProfit |
| Operating income | 3 months, 2017-04-01 to 2017-06-30 | $39.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2017-01-01 to 2017-06-30 | $85.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-04-01 to 2017-06-30 | $9.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2017-01-01 to 2017-06-30 | $21.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-04-01 to 2017-06-30 | $27.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2017-01-01 to 2017-06-30 | $59.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-04-01 to 2017-06-30 | $1.19 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2017-01-01 to 2017-06-30 | $2.56 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-04-01 to 2017-06-30 | $1.21 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2017-01-01 to 2017-06-30 | $2.61 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-04-01 to 2017-06-30 | 23,381,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2017-01-01 to 2017-06-30 | 23,356,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months, 2017-01-01 to 2017-06-30 | $38.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2017-01-01 to 2017-06-30 | $9.2m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2017-01-01 to 2017-06-30 | $1.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-06-30 | $223.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-06-30 | $733.4m | us-gaap:AssetsCurrent |
| Total assets | at 2017-06-30 | $1.41bn | us-gaap:Assets |
| Current liabilities | at 2017-06-30 | $274.4m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2017-06-30 | $283.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-06-30 | $21.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2017-06-30 | $707.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 74,367 characters.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim periods included in the accompanying condensed consolidated financial statements.

Certain statements in this Quarterly Report on Form 10-Q, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These statements include statements about Stepan Company’s and its subsidiaries’ (the Company) plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Company’s control, that could cause the Company’s actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. Such risks, uncertainties and other important factors, include, among others, the risks, uncertainties and factors set forth under “Part I-Item IA. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016: the risks and uncertainties related to disruptions in production or accidents at, or loss of, any of the Company’s manufacturing facilities; global competition and the Company’s ability to successfully compete; volatility of raw material, natural gas and electricity costs as well as any disruption in their supply; disruptions in transportation or significant changes in transportation costs; reduced demand for Company products due to customer product reformulations or new technologies; the Company’s ability to make acquisitions of suitable candidates and successfully integrate acquisitions; the Company’s ability to keep and protect its intellectual property rights; international business risks, including fluctuations in currency exchange rates, legal restrictions and taxes; potentially adverse tax consequences due to the international scope of the Company’s operations; compliance with anti-corruption, environmental, health and safety and product registration laws; the Company’s ability to accurately estimate and maintain appropriate levels of recorded liabilities for existing and future contingencies; the Company’s ability to operate within the limitations of its debt covenants; downgrades to the Company’s credit ratings or disruptions to the Company’s ability to access well-functioning capital markets; downturns in certain industries and general economic downturns; conflicts, military actions, terrorist attacks and general instability, particularly in certain energy-producing nations, along with increased security regulations; cost overruns, delays and miscalculations in capacity needs with respect to the Company’s expansion or other capital projects; interruption of, damage to or compromise of the Company’s IT systems and failure to maintain the integrity of customer, colleague or Company data; unfavorable resolution of litigation against us; and the Company’s ability to retain its executive management and other key personnel. These factors are not necessarily all of the important factors that could cause the Company’s actual financial results, performance, achievements or prospects to differ materially from those expressed in or implied by any of its forward-looking statements. Other unknown or unpredictable factors also could harm the Company’s results. All forward-looking statements attributable to the Company or persons acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and the Company does not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If the Company updates one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect to those or other forward-looking statements. The “Company,” “we,” “our” or “us” means Stepan Company and one or more of its subsidiaries only.

### Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

- Surfactants – Surfactants, which accounted for 67 percent of Company consolidated net sales for the first half of 2017, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at four North American sites (United States), three European sites (United Kingdom, France and Germany), four Latin American sites (Mexico, Colombia and two sites in Brazil) and two Asian sites (Philippines and Singapore). In 2016, the Company shut down its production facility in Canada, moving the production of goods previously manufactured in Canada to other Company North American production sites. Manufacturing operations at that facility ceased in the fourth quarter of 2016. Decommissioning activities will continue throughout 2017. In October 2016, the Company’s subsidiary in Brazil acquired the commercial business of Tebras Tensoativos do Brazil Ltda. (Tebras) and the

sulfonation production facility of PBC Industria Quimica Ltda (PBC). The acquisition is expected to expand and diversify the Company’s customer base for sulfonated products in Brazil and to provide an opportunity to sell the Company’s broader surfactant portfolio to over 1,200 new customers who could benefit from the Company’s technical service and formulation support. See the “Acquisition Agreement” section in this “Overview” for a description of recent acquisition activity.

- Polymers – Polymers, which accounted for 28 percent of consolidated net sales for the first half of 2017, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively, CASE products). Powdered polyester resins are used in coating applications. CASE and polyester resins are collectively referred to as specialty polyols. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the United States, polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and specialty polyols are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyurethane polyols are manufactured by the Company’s subsidiary at its site in Wesseling, Germany, and specialty polyols are manufactured by the Company’s subsidiary at its site in Brzeg Dolny, Poland. In China, polyurethane polyols and specialty polyols are produced at the Company’s Nanjing, China, manufacturing plant.
- Specialty Products – Specialty products, which accounted for five percent of consolidated net sales for the first half of 2017, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

#### Acquisition Agreement

On June 13, 2017, the Company announced that it had reached an agreement with BASF Mexicana, S.A. DE C.V. (BASF) to acquire BASF’s production facility in Ecatepec, Mexico, and a portion of its related surfactants business. The facility, which is near Mexico City, has over 50,000 metric tons of capacity, 124,000 square feet of warehouse space, a laboratory and office space. The acquisition is expected to be completed in the fourth quarter of 2017, subject to applicable regulatory approvals and other closing conditions. The acquisition is not expected to have a material effect on the Company’s 2017 financial results. The acquisition supports the Company’s growth strategy in Latin America. The Company believes that this acquisition should enhance its market position and supply capabilities for surfactants in Mexico and positions the Company to grow in both the consumer and functional surfactants markets.

#### Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities for the three and six months ended June 30, 2017 and 2016 and the income statement line items in which the effects of the activities were recorded are displayed in the following tables:

*(In millions)*

|  | Income (Expense) For the Three Months Ended June 30 2017 | 2016 | Change |  |
| --- | ---: | ---: | ---: | ---: |
| Deferred Compensation (Operating expenses) | $(5.0) | $(2.4) | $(2.6) | (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.9 | 0.1 | 0.8 |  |
| Investment Income (Other, net) | — | — | — |  |
| Pretax Income Effect | $(4.1) | $(2.3) | $(1.8) |  |

*(In millions)*

|  | Income (Expense) For the Six Months Ended June 30 2017 | 2016 | Change |  |
| --- | ---: | ---: | ---: | ---: |
| Deferred Compensation (Operating expenses) | $(5.4) | $(5.2) | $(0.2) | (1) |
| Realized/Unrealized Gains (Losses) on Investments (Other, net) | 2.5 | (0.2) | 2.7 |  |
| Investment Income (Other, net) | 0.1 | 0.2 | (0.1) |  |
| Pretax Income Effect | $(2.8) | $(5.2) | $2.4 |  |

(1) See the applicable Corporate Expenses section of this MD&A for details regarding the changes in deferred compensation expense.

#### Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income line items for the three and six months ended June 30, 2017 and 2016:

*(In millions)*

|  | Three Months Ended June 30 2017 | 2016 | Increase (Decrease) | (Decrease) Due to Foreign Currency Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $495.1 | $454.6 | $40.5 | $(4.1) |
| Gross Profit | 90.0 | 92.9 | (2.9) | (0.3) |
| Operating Income | 39.0 | 42.9 | (3.9) | (0.1) |
| Pretax Income | 37.1 | 39.2 | (2.1) | (0.1) |

*(In millions)*

|  | Six Months Ended June 30 2017 | 2016 | Increase (Decrease) | (Decrease) Due to Foreign Currency Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $963.4 | $900.5 | $62.9 | $(8.6) |
| Gross Profit | 182.1 | 186.4 | (4.3) | (0.4) |
| Operating Income | 85.0 | 87.5 | (2.5) | (0.1) |
| Pretax Income | 81.4 | 79.7 | 1.7 | (0.2) |

21

RESULTS OF OPERATIONS

#### Three Months Ended June 30, 2017 and 2016

### Summary

Net income attributable to the Company for the second quarter of 2017 declined two percent to $27.9 million, or $1.19 per diluted share, from $28.5 million, or $1.24 per diluted share, for the second quarter of 2016. Adjusted net income increased one percent to $30.9 million, or $1.32 per diluted share, from $30.7 million, or $1.33 per diluted share (see the “Reconciliation of Non-GAAP Adjusted Net Income and Diluted Earnings per Share” section of this MD&A for reconciliations between reported net income attributable to the Company and related earnings per diluted share and non-GAAP adjusted net income and related earnings per diluted share). Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the second quarter of 2017 compared to the second quarter of 2016 follows the summary.

Consolidated net sales increased $40.5 million, or nine percent, between quarters. The increase was attributable to higher selling prices, which favorably affected the quarter-over-quarter change in net sales by $62.5 million. The pass through of certain increased raw material costs led to the increased selling prices. Sales volume declined four percent, which unfavorably impacted the quarter-over-quarter change in net sales by $17.9 million. Specialty Product sales volume increased three percent between quarters, while Surfactant and Polymer sales volumes declined three percent and seven percent, respectively. The effects of foreign currency translation negatively impacted the quarter-over-quarter net sales change by $4.1 million.

Operating income for the second quarter of 2017 decreased $4.0 million, or nine percent, from operating income for the second quarter of 2016. Consolidated operating income was negatively affected by deferred compensation expense which increased $2.6 million quarter over quarter. With respect to the segments, Surfactant and Specialty Product operating incomes improved but were more than offset by a decline in Polymer results. Polymer operating income was negatively impacted by higher raw material costs and lower sales volume.

Operating expenses (including business restructuring expenses) for the second quarter of 2017 increased $1.0 million, or two percent, over operating expenses for the second quarter of 2016. Changes in the individual income statement line items that comprise the Company’s operating expenses were as follows:

- Selling expenses declined $1.3 million, or nine percent, quarter over quarter. The decrease was primarily attributable to lower bad debt expense ($0.5 million) and the accumulation of smaller decreases for a number of other expense items.
- Administrative expenses increased $0.2 million, or one percent, quarter over quarter.
- Research, development and technical service (R&D) expenses increased less than $0.1 million.
- Deferred compensation expense increased $2.6 million, or 106 percent, quarter over quarter primarily due to a larger increase in the market price of Company common stock in the second quarter of 2017 than in the second quarter of 2016. Greater investment gains from mutual fund investments held to fund the deferred compensation plan liabilities also contributed. See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details.
- Business restructuring expenses were $0.6 million in the second quarter of 2017 compared to $1.1 million in the same quarter of last year. Approximately $0.5 million of the restructuring expense related to the continued asset decommissioning for the Company’s plant in Canada, which ceased operations in the fourth quarter of 2016. The remaining $0.1 million of restructuring expense related to a second quarter 2017 workforce reduction at the Company’s Singapore plant. The reduction in positions was made to better align the number of personnel with current business requirements and to reduce costs at that site. See Note 14 to the condensed consolidated financial statements for additional information regarding the Company’s restructuring activities.

Net interest expense for the second quarter of 2017 declined $0.6 million, or 16 percent, from net interest expense for the second quarter of 2016 primarily due to lower average debt levels and higher interest income earned on excess cash.

Other, net was $1.0 million of income for the second quarter of 2017 compared to $0.3 million of expense for the same period of 2016. The Company reported $1.0 million of investment gains (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets in the second quarter of 2017 compared to $0.2 million of income in last year’s second quarter. In addition, foreign exchange losses totaled less than $0.1 million in the second quarter of 2017 compared to losses of $0.5 million in same period of 2016.

The effective tax rate was 24.7 percent for the second quarter of 2017 compared to 27.3 percent for the second quarter of 2016. The most significant contributor to the decrease was higher excess tax benefits derived from stock based compensation awards exercised or distributed in the second quarter of 2017 versus the second quarter of 2016.

### Segment Results

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended June 30, 2017 | June 30, 2016 | Increase | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $329,334 | $298,587 | $30,747 | 10 |
| Polymers | 141,187 | 134,498 | 6,689 | 5 |
| Specialty Products | 24,580 | 21,518 | 3,062 | 14 |
| Total Net Sales | $495,101 | $454,603 | $40,498 | 9 |

*(Dollars in thousands)*

| Operating Income | For the Three Months Ended June 30, 2017 | June 30, 2016 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $31,030 | $27,232 | $3,798 | 14 |
| Polymers | 21,257 | 30,994 | (9,737) | -31 |
| Specialty Products | 5,439 | 1,788 | 3,651 | 204 |
| Segment Operating Income | $57,726 | $60,014 | $(2,288) | -4 |
| Corporate Expenses, Excluding Deferred Compensation and Restructuring | 13,163 | 13,603 | (440) | -3 |
| Deferred Compensation Expense | 5,016 | 2,434 | 2,582 | 106 |
| Business Restructuring | 586 | 1,061 | (475) | -45 |
| Total Operating Income | $38,961 | $42,916 | $(3,955) | -9 |

#### Surfactants

Surfactant net sales for the second quarter of 2017 increased $30.7 million, or 10 percent, over net sales for the second quarter of 2016. Higher selling prices, resulting primarily from the pass through of higher costs for certain raw materials, had a favorable $44.4 million effect on the quarter-over-quarter change in net sales. A three percent decline in sales volume and the unfavorable effects of foreign currency translation offset the impact of increased selling prices by $9.3 million and $4.4 million, respectively. The Latin America region reported improved sales volume due to sales volume associated with the October 2016 acquisitions of Tebras and PBC, while sales volumes in other regions declined. A quarter-over-quarter comparison of net sales by region follows:

*(Dollars in thousands)*

|  | For the Three Months Ended June 30, 2017 | June 30, 2016 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $199,016 | $185,714 | $13,302 | 7 |
| Europe | 65,289 | 57,420 | 7,869 | 14 |
| Latin America | 48,559 | 37,720 | 10,839 | 29 |
| Asia | 16,470 | 17,733 | (1,263) | -7 |
| Total Surfactants Segment | $329,334 | $298,587 | $30,747 | 10 |

Net sales for North American operations increased seven percent between quarters. Higher selling prices favorably affected the quarter-over-quarter change in net sales by $21.7 million. A four percent decline in sales volume and the unfavorable effect of foreign currency translation offset the impact of higher selling prices by $8.0 million and $0.4 million, respectively. On average, selling prices increased 12 percent quarter over quarter, mainly as a result of the pass through of certain increased raw material costs to customers, and a more favorable mix of sales. Declines in sales volume for commodity products used in laundry and cleaning and personal care applications, due to lower demand from existing customers, accounted for most of the North American surfactant sales volume decrease. Increased sales volumes of products used in household, industrial and institutional (HI&I), agricultural chemical and oilfield applications partially offset the declines in sales volumes of commodity laundry and cleaning and personal care products. The increases were principally attributable to stronger demand from major customers.

Net sales for European operations increased 14 percent due to a 24 percent increase in selling prices, partially offset by the unfavorable effects of foreign currency translation and a three percent decline in sales volume. The selling price increase, which primarily resulted from the pass through of higher costs for certain raw materials, had a $13.5 million positive impact on the quarter- over-quarter change in net sales, while foreign currency translation and lower sales volume unfavorably affected the net sales change by $4.0 million and $1.6 million, respectively. The decrease in sales volume was primarily attributable to lower demand for general surfactants sold to distributors and for commodity personal care products, partially offset by increased sales volumes for laundry and cleaning products and agricultural chemicals. The decline in commodity personal care sales volume was attributable to lost business for the period resulting from uncompetitive pricing precipitated by a disadvantaged cost position for certain raw materials. A stronger U.S. dollar relative to the British pound sterling and European euro led to the foreign currency translation effect.

Net sales for Latin American operations increased 29 percent due to higher selling prices, a nine percent increase in sales volume and the favorable effects of foreign currency translation, which accounted for $6.2 million, $3.5 million and $1.1 million, respectively, of the quarter-over-quarter increase in net sales. The improved sales volume reflected new business associated with the October 2016 acquisitions of Tebras and PBC, partially offset by lower demand and lost commodity business for products used in laundry and cleaning applications. Selling prices increased 15 percent due to the pass through to customers of higher quarter-over-quarter raw material costs and a more favorable mix of sales. The foreign currency translation effect primarily resulted from the quarter-over-quarter strengthening of the Brazilian real relative to the U.S. dollar.

Net sales for Asian operations declined seven percent largely due to a 23 percent decrease in sales volume and the unfavorable effects of foreign currency translation, which negatively affected the quarter-over-quarter change in net sales by $4.2 million and $1.1 million, respectively. Higher selling prices, driven by the pass through of certain increased raw material costs to customers, favorably impacted the change in net sales by $4.0 million. The sales volume decline was primarily due to weaker demand for commodity laundry and cleaning products. A weaker Philippine peso relative to the U.S. dollar caused the negative foreign currency translation effect.

Surfactant operating income for the second quarter of 2017 increased $3.8 million, or 14 percent, over operating income for the second quarter of 2016. Gross profit increased $3.1 million on improved results from all regions except Asia. Operating expenses decreased $0.7 million, or three percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit | For the Three Months Ended June 30, 2017 | June 30, 2016 (a) | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $37,048 | $35,355 | $1,693 | 5 |
| Europe | 5,767 | 5,292 | 475 | 9 |
| Latin America | 7,690 | 6,417 | 1,273 | 20 |
| Asia | 4,034 | 4,413 | (379) | -9 |
| Surfactants Segment Gross Profit | $54,539 | $51,477 | $3,062 | 6 |
| Operating Expenses | 23,509 | 24,245 | (736) | -3 |
| Surfactants Segment Operating Income | $31,030 | $27,232 | $3,798 | 14 |

(a) In 2017, the Company changed its internal financial statement classification for certain transportation costs, transferring such costs from operating expenses to cost of sales. In this segment discussion, the 2016 North America gross profit and total operating expenses have been changed from the amounts presented in 2016 to make such amounts consistent with the current year classification. Surfactants segment operating income remained unchanged.

Gross profit for North American operations increased five percent quarter over quarter largely due to a more profitable sales mix of products and lower manufacturing overhead costs resulting from the closure of the Company’s Canada manufacturing operations in the fourth quarter of 2016.

Gross profit for European operations increased nine percent between quarters largely due to higher second quarter 2016 expenses arising from a charge to record a customer claim, which did not recur in 2017. The lower quarter-over-quarter expense more than offset the effect of the three percent decline in sales volume and a $0.3 million negative impact for foreign currency translation.

Gross profit for Latin American operations increased 20 percent due to the nine percent improvement in sales volume, a more profitable mix of sales and a $0.3 million favorable effect of foreign currency translation.

Gross profit for Asia declined nine percent quarter over quarter primarily due to the 23 percent decrease in sales volume. The impact of the sales volume decline was partially offset by better sales margins precipitated by a more favorable mix of sales.

Operating expenses for the Surfactant segment declined $0.7 million, or three percent, quarter over quarter principally due to lower U.S. marketing expenses.

#### Polymers

Polymer net sales for the second quarter of 2017 increased $6.7 million, or five percent, over net sales for the second quarter of 2016. Higher selling prices, resulting from the pass through of increased costs for certain raw materials, favorably affected the quarter-over-quarter net sales increase by $15.3 million. Sales volume declined seven percent, which negatively impacted the change in net sales by $8.9 million. All polymer regions reported decreased sales volumes. The effects of foreign currency translation had a $0.3 million positive effect on net sales. A quarter-over-quarter comparison of net sales by region follows:

*(Dollars in thousands)*

|  | For the Three Months Ended June 30, 2017 | June 30, 2016 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $86,925 | $85,131 | $1,794 | 2 |
| Europe | 46,854 | 41,364 | 5,490 | 13 |
| Asia and Other | 7,408 | 8,003 | (595) | -7 |
| Total Polymers Segment | $141,187 | $134,498 | $6,689 | 5 |

Net sales for North American operations increased two percent due to higher selling prices, partially offset by lower sales volume. Selling prices increased eight percent, which had a $6.2 million positive effect on the quarter-over-quarter change in net sales. The pass through of certain higher quarter-over-quarter raw material costs to customers led to the increased selling prices. Sales volume declined five percent, which unfavorably impacted the net sales change by $4.4 million. Sales volume of polyols used in rigid foam applications declined three percent mainly due to lost share from a customer. Phthalic anhydride sales volume declined 16 percent, as last year’s volumes benefited from sales to a phthalic anhydride co-producer resulting from an extended maintenance shutdown that did not recur in 2017. Sales volume of specialty polyols increased five percent due to greater demand for product used in CASE applications.

Net sales for European operations increased 13 percent due to higher selling prices and the favorable effects of foreign currency translation, which accounted for $7.8 million and $0.5 million, respectively, of the quarter-over-quarter net sales increase. Selling prices increased 20 percent primarily due to the pass through of cost increases for certain raw materials. Sales volume declined seven percent, which had a $2.8 million negative effect on the net sales change. Reduced demand from a number of existing customers using polyols in rigid foam insulation led to the decline in sales volume. A market-wide shortage of third-party material needed to blend and react with the Company’s polyol product led to the reduced polyol demand. Sales volume for specialty polyols used in CASE applications increased 31 percent quarter over quarter, which reflected the Company’s successful efforts to utilize the capacity of its new reactor in Poland.

Net sales for Asia and Other operations declined seven percent quarter over quarter due primarily to a decline in sales volume.

Polymer operating income for the second quarter of 2017 declined $9.7 million, or 31 percent, from operating income for the same period of last year. Gross profit decreased $9.9 million, or 26 percent, primarily due to higher material costs and lower sales volume. All regions reported lower quarter-over-quarter gross profit. Operating expenses declined $0.2 million, or three percent, between quarters. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit | For the Three Months Ended June 30, 2017 | June 30, 2016 (a) | Decrease | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $21,400 | $28,502 | $(7,102) | -25 |
| Europe | 7,208 | 8,806 | (1,598) | -18 |
| Asia and Other | (166) | 1,066 | (1,232) | NM |
| Polymers Segment Gross Profit | $28,442 | $38,374 | $(9,932) | -26 |
| Operating Expenses | 7,185 | 7,380 | (195) | -3 |
| Polymers Segment Operating Income | $21,257 | $30,994 | $(9,737) | -31 |

(a) In 2017, the Company changed its internal financial statement classification for certain transportation costs, transferring such costs from operating expenses to cost of sales. In this segment discussion, the 2016 North America gross profit and total operating expenses have been changed from the amounts presented in 2016 to make such amounts consistent with the current year classification. Polymers segment operating income remained unchanged.

Gross profit for North American operations declined 25 percent quarter over quarter primarily due to higher raw material costs, which reduced margins, and the five percent decline in sales volume. Competitive pressure prohibited the Company from passing through the full extent of raw material increases to customers.

Gross profit for European operations declined 18 percent due to reduced sales margins driven by higher raw material costs and due to the previously discussed seven percent decrease in sales volume.

Gross profit for Asia and Other operations declined $1.2 million due to higher overhead costs resulting from not yet fully utilizing the operating capacity at the plant in Nanjing, China, and to the 17 percent decline in sales volume. In addition, last year’s second quarter benefited from production of polyol to build up inventory to support the Company’s Germany plant in advance of its mandatory third quarter 2016 inspection shutdown.

Operating expenses for the Polymers segment declined $0.2 million, or three percent, quarter over quarter. Selling expenses declined $0.4 million primarily due to lower bad debt expense in Europe. The decrease in selling expenses was partially offset by increased R&D expense.

#### Specialty Products

Net sales for the second quarter of 2017 increased $3.1 million, or 14 percent, over net sales for the second quarter of 2016. A more favorable mix of sales resulting from the timing of orders for certain products used in flavor applications and a three percent increase in sales volume led to the higher net sales. Operating income increased $3.7 million quarter over quarter due to the favorable mix of flavor products and to improved margins for food ingredient and nutritional supplement products.

#### Corporate Expenses

Corporate expenses, which are comprised of deferred compensation and other operating expenses that are not allocated to the reportable segments, increased $1.7 million between quarters to $18.8 million for the second quarter of 2017 from $17.1 million for the second quarter of 2016. The increase in corporate expense was primarily attributable to higher expenses for deferred compensation ($2.6 million) and consulting fees ($0.5 million), partially offset by a decrease in the previously discussed restructuring expenses ($0.5 million) and the accumulation of a number of items with smaller declines.

The $2.6 million increase in deferred compensation expense reflected an $8.33 per share increase in the value of Company common stock in the second quarter of 2017 compared to a $4.24 per share increase for the second quarter of 2016. A greater quarter-over-quarter increase in the value of the mutual fund investments held for the Company’s deferred compensation plans also contributed to the increased deferred compensation expense. The following table presents the quarter-end Company common stock market prices used in the computation of deferred compensation expenses for the three months ended June 30, 2017 and 2016:

|  | 2017 June 30 | March 31 | 2016 June 30 | March 31 |
| --- | ---: | ---: | ---: | ---: |
| Company Common Stock Price | $87.14 | $78.81 | $59.53 | $55.29 |

#### Six Months Ended June 30, 2017 and 2016

### Summary

Net income attributable to the Company for the first half of 2017 increased six percent to $59.8 million, or $2.56 per diluted share, from $56.4 million, or $2.46 per diluted share, for the first half of 2016. Adjusted net income increased four percent to $62.6 million, or $2.68 per diluted share, from $60.4 million, or $2.63 per diluted share (see the “Reconciliation of Non-GAAP Adjusted Net Income and Diluted Earnings per Share” section of this MD&A for reconciliations between reported net income attributable to the Company and related earnings per diluted share and non-GAAP adjusted net income and related earnings per diluted share). Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first half of 2017 compared to the first half of 2016 follows the summary.

Consolidated net sales increased $62.9 million, or seven percent, between years, primarily due to higher selling prices that were precipitated by increased raw material costs. The increased selling prices favorably affected the year-over-year change in net sales by $105.6 million. Sales volume declined four percent, which had a $34.1 million unfavorable effect on the change in net sales. Sales volume declined five percent and two percent for the Surfactant and Specialty Products segments, respectively, and was flat between years for the Polymer segment. Foreign currency translation negatively impacted the net sales change by $8.6 million. The unfavorable foreign currency translation effect reflected a stronger U.S. dollar against nearly all currencies for countries where the Company has foreign operations (excepting currencies for Colombia and Brazil).

Operating income for the first half of 2017 declined $2.5 million, or three percent, from operating income reported for the first half of 2016. Surfactant and Specialty Product operating incomes improved year over year but were more than offset by a decline in Polymer results. Polymer operating income was negatively impacted by higher raw material costs that could not entirely be recouped through selling price increases.

Operating expenses (including the business restructuring expenses) declined $1.9 million, or two percent, between years. Changes in the individual income statement line items that comprise the Company’s operating expenses were as follows:

- Selling expenses declined $1.5 million, or five percent, year over year largely due to lower bad debt expense ($0.9 million) and the accumulation of smaller decreases for a number of other expense items.
- Administrative expenses declined $0.6 million, or two percent, year over year. Lower U.S. expenses for legal and environmental ($0.7 million), hiring ($0.4 million), relocation ($0.4 million) and the accumulation of a number of smaller items, partially offset by increased expenses for consulting ($1.4 million), led to the decrease in administrative expenses. The decline in legal and environmental expense was principally a result of first half 2016 environmental remediation expenses that did not recur in the first half of 2017. The increase in consulting fees was primarily attributable to external resources engaged in 2017 to support certain strategic projects.
- R&D expenses declined $0.3 million, or one percent, year over year largely due to lower U.S. fringe benefits expense.
- Deferred compensation expense increased $0.2 million, or five percent, year over year primarily due to a greater year-over-year increase in the value of the mutual fund investments held to fund the deferred compensation plan that was largely offset by a smaller year-over-year increase in the value of Company common stock. See the “Overview” and “Corporate Expenses” sections of this MD&A for further details.
- Business restructuring expenses were $1.4 million in the first half of 2017 compared to $1.1 million in the first half of 2016. Approximately $1.3 million of the restructuring expense related to the continued asset decommissioning for the Company’s plant in Canada, which ceased operations in the fourth quarter of 2016. The remaining $0.1 million of restructuring expense related to a second quarter 2017 workforce reduction at the Company’s Singapore plant. The reduction in positions was made to better align the number of personnel with current business requirements and to reduce costs at that site. See Note 14 to the condensed consolidated financial statements for additional information regarding the Company’s restructuring activities.

Net interest expense for the first half of 2017 declined $1.2 million, or 17 percent, from net interest expense for the first half of 2016 primarily due to lower average debt levels and higher interest income earned on excess cash.

Other, net was $2.2 million of income for the first half of 2017 compared to $0.8 million of expense for the same period of last year. The Company posted $2.7 million of investment gains (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets in the first half of 2017 compared to $0.1 million of losses in the first half of 2016. In addition, the Company reported foreign exchange losses of $0.5 million in the first half of 2017 compared to exchange losses of $0.8 million in the first half of 2016.

The effective tax rate was 26.5 percent for the first half of 2017 compared to 29.2 percent for the first half of 2016. The decrease was attributable to the following items: 1) higher excess tax benefits derived from stock based compensation awards exercised or distributed in the first half of 2017 versus the first half of 2016; and 2) an unfavorable tax settlement related to a foreign income tax audit recorded in the first quarter of 2016 that did not recur in 2017.

### Segment Results

*(Dollars in thousands)*

| Net Sales | For the Six Months Ended June 30, 2017 | June 30, 2016 | Increase | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $651,937 | $608,547 | $43,390 | 7 |
| Polymers | 267,797 | 248,396 | 19,401 | 8 |
| Specialty Products | 43,636 | 43,557 | 79 | — |
| Total Net Sales | $963,370 | $900,500 | $62,870 | 7 |

*(Dollars in thousands)*

| Operating Income | For the Six Months Ended June 30, 2017 | June 30, 2016 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $69,267 | $64,477 | $4,790 | 7 |
| Polymers | 42,656 | 53,191 | (10,535) | -20 |
| Specialty Products | 6,714 | 4,121 | 2,593 | 63 |
| Segment Operating Income | $118,637 | $121,789 | $(3,152) | -3 |
| Corporate Expenses, Excluding Deferred Compensation and Restructuring | 26,853 | 28,051 | (1,198) | -4 |
| Deferred Compensation Expense | 5,392 | 5,154 | 238 | 5 |
| Business Restructuring | 1,372 | 1,061 | 311 | 29 |
| Total Operating Income | $85,020 | $87,523 | $(2,503) | -3 |

#### Surfactants

Surfactant net sales for the first half of 2017 increased $43.4 million, or seven percent, over net sales for the first half of 2016. Higher selling prices, resulting primarily from the pass through of higher costs on certain raw materials to customers, had a favorable $80.9 million effect on the year-over-year change in net sales. A five percent decline in sales volume and the unfavorable effects of foreign currency translation offset the impact of increased selling prices by $30.0 million and $7.5 million, respectively. The Latin America region reported improved sales volume due to sales volume associated with the October 2016 acquisitions of Tebras and PBC while sales volumes for the other regions declined. A year-over-year comparison of net sales by region follows:

*(Dollars in thousands)*

|  | For the Six Months Ended June 30, 2017 | June 30, 2016 | Increase | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $397,259 | $380,995 | $16,264 | 4 |
| Europe | 128,712 | 120,951 | 7,761 | 6 |
| Latin America | 92,064 | 73,803 | 18,261 | 25 |
| Asia | 33,902 | 32,798 | 1,104 | 3 |
| Total Surfactants Segment | $651,937 | $608,547 | $43,390 | 7 |

Net sales for North American operations increased four percent year over year. Higher selling prices favorably impacted the change in net sales by $39.6 million. Sales volume declined six percent, which offset the effect of increased selling prices by $23.3 million. Average selling prices increased 11 percent between years, reflecting the pass through of certain higher raw material costs to customers and a more favorable mix of sales. Declines in sales volume for commodity products used in laundry and cleaning and personal care applications accounted for most of the North American surfactant sales volume decrease. Sales volumes increased for products used in household, industrial and institutional (HI&I) and oilfield applications. The increase in HI&I sales volume was principally attributable to stronger demand from a large customer. Volumes for surfactants used in oilfield solutions also improved, largely due to increased requirements from existing customers and to sales volumes associated with new oilfield products.

Net sales for European operations increased six percent due to a 20 percent increase in selling prices, partially offset by the unfavorable effects of foreign currency translation and a five percent decline in sales volume. The higher selling prices, which resulted from the pass through to customers of certain increased raw material costs, favorably impacted the year-over-year change in net sales by $23.4 million, while foreign currency translation and lower sales volume unfavorably affected the net sales change by $9.0 million and $6.6 million, respectively. A stronger U.S. dollar relative to the British pound sterling and European euro led to the foreign currency translation effect. The decrease in sales volume primarily resulted from a decline in commodity personal care sales volume that was attributable to lost business for the period resulting from uncompetitive pricing precipitated by a disadvantaged cost position for certain raw materials.

Net sales for Latin American operations increased 25 percent due to increased selling prices, the favorable effects of foreign currency translation and a four percent improvement in sales volume, which accounted for $11.7 million, $3.6 million and $3.0 million, respectively, of the year-over-year increase in net sales. The higher selling prices reflected the pass through to customers of increased raw material costs and a more favorable mix of sales resulting from higher agricultural product sales volumes and lower commodity laundry and cleaning volumes. The foreign currency translation effect reflected the year-over-year strengthening of the Brazilian real and Colombian peso relative to the U.S. dollar, partially offset by a weaker Mexican peso. The improved sales volume reflected new business associated with the October 2016 acquisitions of Tebras and PBC, partially offset by lower demand and lost business for commodity products used in laundry and cleaning applications.

Net sales for Asian operations increased three percent primarily due to higher selling prices, which positively affected the year-over-year change in net sales by $8.3 million. The pass through to customers of certain increased raw material costs led to the higher selling prices. The effect of the selling price increases was partially offset by a 16 percent decline in sales volume and the unfavorable effects of foreign currency translation, which negatively impacted the net sales change by $5.2 million and $2.0 million, respectively. The sales volume decline was primarily due to weaker demand for commodity laundry and cleaning products. A weaker Philippine peso relative to the U.S. dollar caused the negative foreign currency translation effect.

Surfactant operating income for the first half of 2017 increased $4.8 million, or seven percent, over operating income for the first half of 2016. Gross profit increased $3.4 million, primarily due to improved results for North American operations. Operating expenses decreased $1.4 million, or three percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit | For the Six Months Ended June 30, 2017 | June 30, 2016 (a) | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $80,080 | $73,609 | $6,471 | 9 |
| Europe | 11,813 | 14,775 | (2,962) | -20 |
| Latin America | 14,934 | 13,406 | 1,528 | 11 |
| Asia | 8,534 | 10,221 | (1,687) | -17 |
| Surfactants Segment Gross Profit | $115,361 | $112,011 | $3,350 | 3 |
| Operating Expenses | 46,094 | 47,534 | (1,440) | -3 |
| Surfactants Segment Operating Income | $69,267 | $64,477 | $4,790 | 7 |

(a) In 2017, the Company changed its internal financial statement classification for certain transportation costs, transferring such costs from operating expenses to cost of sales. In this segment discussion, the 2016 North America gross profit and total operating expenses have been changed from the amounts presented in 2016 to make such amounts consistent with the current year classification. Surfactants segment operating income remained unchanged.

Gross profit for North American operations increased nine percent between years. The effect of improved margins more than offset the impact of the six percent sales volume decline. The margin improvement reflected a more profitable mix of sales and reduced manufacturing overhead costs resulting from the closure of the Company’s Canada manufacturing operations in the fourth quarter of 2016.

Gross profit for European operations declined 20 percent year over year primarily due to reduced sales margins, the five percent sales volume decline and a $0.7 million unfavorable foreign currency translation impact. The lower sales margins reflected the effect of increased raw material costs that could not be entirely passed on through selling price increases. The year-over-year change in gross profit benefitted from a 2016 charge for a customer claim that did not recur in 2017.

Gross profit for Latin American operations increased 11 percent due to a $0.8 million favorable effect for foreign currency translation, the four percent improvement in sales volume and a more profitable mix of sales primarily resulting from a larger sales volume of agricultural chemicals and from new sales related to the Tebras acquisition.

Asia gross profit declined 17 percent largely due to the 16 percent decline in sales volume and to a year-over-year decline in production volume in Singapore, which led to higher unit overhead costs. A $0.4 million unfavorable foreign currency translation effect also contributed to the decline in gross profit. The Company’s intent to lower inventory levels in the region led to the decrease in Singapore production. The impact of the sales volume and production declines were partially offset by better sales margins precipitated by a more favorable mix of sales.

Operating expenses for the Surfactant segment declined $1.4 million, or three percent, year over year. Selling and R&D expenses each declined $0.9 million, due primarily to lower overall expenses in the U.S. Partially offsetting the declines in selling and administrative expenses were higher administrative expenses that reflected operating costs for Tebras and PBC, which were acquired in October 2016.

#### Polymers

Polymer net sales for the first half of 2017 increased $19.4 million, or eight percent, over net sales for the same period of 2016. Higher selling prices, primarily resulting from the pass through to customers of certain increased raw material costs, favorably affected the year-over-year net sales increase by $20.2 million. Polymer sales volume was flat between years. The effects of foreign currency translation negatively impacted the net sales change by $0.8 million. A year-over-year comparison of net sales by region follows:

*(Dollars in thousands)*

|  | For the Six Months Ended June 30, 2017 | June 30, 2016 | Increase | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $165,289 | $159,758 | $5,531 | 3 |
| Europe | 89,257 | 77,253 | 12,004 | 16 |
| Asia and Other | 13,251 | 11,385 | 1,866 | 16 |
| Total Polymers Segment | $267,797 | $248,396 | $19,401 | 8 |

Net sales for North American operations increased three percent due to higher selling prices, which favorably affected the year-over-year net sales change by $8.5 million. Selling prices increased five percent, largely as a result of the pass through of higher raw material costs. Sales volume declined two percent between years, which unfavorably affected the net sales change by $3.0 million. Sales volume of polyols used in rigid foam applications increased one percent and sales volume of specialty polyols increased five percent on increased volumes for product used in CASE applications. Phthalic anhydride sales volume declined 11 percent due to less opportunity to supply product to phthalic anhydride co-producers in 2017 than in 2016.

Net sales for European operations increased 16 percent due to higher selling prices and a two percent increase in sales volume, which favorably impacted the year-over-year net sales change by $10.7 million and $1.9 million, respectively. Selling prices increased 13 percent primarily due to pass through certain increased raw material costs to customers. Specialty polyols used in CASE applications accounted for most of the sales volume increase, as sales volume for polyols used in rigid foam insulation and insulated metal panels was flat year-over-year. The increase in CASE sales volumes reflected the Company’s successful efforts to utilize the capacity of its new reactor in Poland. The unfavorable effects of foreign currency translation offset the effects of the increased sales prices and volumes by $0.6 million.

Net sales for Asia and Other operations increased 16 percent quarter over quarter due to higher selling prices and a five percent increase in sales volume, which accounted for $1.5 million and $0.6 million, respectively, of the year-over-year net sales change. Increased raw material costs drove the selling price increase. Most of the sales volume increase reflected new business for the Company’s manufacturing facility in Nanjing, China, that commenced operations in early 2016. Foreign currency translation had a $0.2 million negative effect on the year-over-year change in net sales.

Polymer operating income for the first half of 2017 declined $10.5 million, or 20 percent, from operating income for the first half of 2016. Gross profit decreased $10.4 million, or 15 percent, primarily due to higher material costs. All regions reported lower year-over-year gross profit. Operating expenses increased $0.1 million, or one percent between years. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit | For the Six Months Ended June 30, 2017 | June 30, 2016 (a) | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $42,654 | $49,952 | $(7,298) | -15 |
| Europe | 14,566 | 16,025 | (1,459) | -9 |
| Asia and Other | (237) | 1,426 | (1,663) | NM |
| Polymers Segment Gross Profit | $56,983 | $67,403 | $(10,420) | -15 |
| Operating Expenses | 14,327 | 14,212 | 115 | 1 |
| Polymers Segment Operating Income | $42,656 | $53,191 | $(10,535) | -20 |

(a) In 2017, the Company changed its internal financial statement classification for certain transportation costs, transferring such costs from operating expenses to cost of sales. In this segment discussion, the 2016 North America gross profit and total operating expenses have been changed from the amounts presented in 2016 to make such amounts consistent with the current year classification. Polymers segment operating income remained unchanged.

Gross profit for North American operations declined 15 percent year over year primarily as a result of higher raw material costs, which reduced margins, and the two percent decline in sales volume. Competitive pressure prohibited the Company from passing through the full extent of raw material increases to customers.

Gross profit for European operations declined nine percent due to reduced sales margins arising from increased raw material costs that could not be entirely passed through to customers. The impact of the higher raw material costs was partially offset by the two percent increase in sales volume. Foreign currency translation had a $0.2 million negative effect on Europe’s gross profit.

Gross profit for Asia and Other operations declined $1.7 million due to higher overhead costs resulting from not yet fully utilizing the operating capacity at the plant in Nanjing, China. In addition, last year’s first half benefited from production of polyol to build up inventory to support the Company’s Germany plant in advance of its mandatory third quarter 2016 inspection shutdown.

#### Specialty Products

Net sales for the first half of 2017 were essentially unchanged from net sales reported for the same period of last year. Sales volume declined two percent, principally as a result of lower sales volumes of products used in food ingredient and nutritional supplement applications partially offset by an increase in sales volume of products used in flavor applications. Operating income increased $2.6 million year over year due to a more favorable mix of sales resulting from the timing of orders for certain products used in flavoring applications.

#### Corporate Expenses

Corporate expenses decreased $0.7 million to $33.6 million for the first half of 2017 from $34.3 million for the first half of 2016. The decline was primarily attributable to lower expenses for legal and environmental ($0.7 million), hiring ($0.4 million) and relocation ($0.4 million), partially offset by increased expenses for consulting fees ($1.4 million). The decline in legal and environmental expense was largely attributable to 2016 environmental remediation expenses that did not recur 2017. The increase in consulting fees reflected external resources engaged in 2017 to support certain strategic projects.

Deferred compensation expense increased $0.2 million between years. The result reflected a greater year-over-year increase in the value of the mutual fund investments held for the Company’s deferred compensation plans largely offset by a smaller year-over-year increase in the value of Company common stock ($5.66 per share increase for the first half of 2017 compared to $9.84 per share increase for the first half of 2016). The following table presents the period-end Company common stock market prices used in the computation of deferred compensation expenses for the six months ended June 30, 2017 and 2016:

|  | 2017 June 30 | 2016 December 31 | June 30 | 2015 December 31 |
| --- | ---: | ---: | ---: | ---: |
| Company Common Stock Price | $87.14 | $81.48 | $59.53 | $49.69 |

#### LIQUIDITY AND CAPITAL RESOURCES

#### Overview

For the six months ended June 30, 2017, operating activities were a cash source of $60.9 million versus a source of $76.3 million for the comparable period in 2016. For the current year, investing cash outflows totaled $44.9 million, as compared to an outflow of $44.2 million in the prior year period, and financing activities were a use of $22.7 million, as compared to a use of $19.8 million in the prior year period. Cash and cash equivalents decreased by $1.9 million compared to December 31, 2016, including a favorable exchange rate impact of $4.7 million.

As of June 30, 2017, the Company’s cash and cash equivalents totaled $223.8 million, including $15.0 million in a U.S. money market fund, which was rated AAA by Standard and Poor’s. Cash in U.S. demand deposit accounts totaled $100.7 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $108.1 million as of June 30, 2017.

#### Operating Activity

Net income increased by $3.4 million versus the comparable period in 2016. Working capital was a cash use of $49.0 million versus a use of $33.3 million for the comparable year-ago period.

Year-to-date accounts receivable were a use of $33.7 million compared to a use of $33.6 million for the comparable period in 2016. Inventories were a use of $1.5 million in 2017 versus a use of $8.7 million in 2016. Accounts payable and accrued liabilities were a use of $11.8 million in 2017 compared to a source of $8.6 million for the same period in 2016.

Working capital requirements were higher year-to-date, compared to the same period in 2016 primarily due to the above noted change in accounts payable and accrued liabilities. Accrued liabilities accounted for most of the change, as balances for certain liabilities were greater at December 31, 2016 than at December 31, 2015, which led to larger cash payments in the first half of 2017 to settle the liabilities than in the same period of 2016. The year-to-date accounts receivables increase was primarily due to price change. The year-to-date inventory increase was due to higher prices and quantities. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2017.

#### Investing Activity

Cash outflows for investing activities were up by $0.6 million year-over-year. Cash outflows from investing activities year-to-date included capital expenditures of $38.3 million compared to $40.7 million for the comparable period last year. Other investing activities consumed $6.5 million in 2017 versus a use of $3.5 million in 2016. The increase in other investing activities was primarily attributable to the $4.3 million purchase price working capital adjustment payment made in the first quarter of 2017 related to the 2016 fourth quarter acquisitions of Tebras and PBC.

For 2017, the Company estimates that total capital expenditures will range from $95 million to $105 million including capacity expansions in the United States, Brazil and Germany.

#### Financing Activity

Cash flow used for financing activities was a use of $22.7 million in 2017 versus a use of $19.8 million in 2016. The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. For the six months ended June 30, 2017, the Company purchased 20,093 shares in the open market at a total cost of $1.5 million. At June 30, 2017, there were 697,836 shares remaining under the current share repurchase authorization.

#### Debt and Credit Facilities

Consolidated balance sheet debt decreased by $12.9 million for the current year, from $321.4 million to $304.4 million, primarily due to a decrease of domestic debt by $5.7 million and foreign debt by $7.2 million. Net debt (which is defined as total debt minus cash) decreased by $10.6 million for the current year, from $91.3 million to $80.6 million.

As of June 30, 2017, the ratio of total debt to total debt plus shareholders’ equity was 30.1 percent compared to 33.3 percent at December 31, 2016. As of June 30, 2017, the ratio of net debt to net debt plus shareholders’ equity was 10.2 percent, compared to 12.6 percent at December 31, 2016. At June 30, 2017, the Company’s debt included $305.0 million of unsecured private placement loans with maturities ranging from 2017 through 2027. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

The Company has a committed $125.0 million multi-currency syndicated revolving credit agreement. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through July 10, 2019, with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of June 30, 2017, the Company had outstanding letters of credit of $5.1 million under the revolving credit agreement, and no borrowings, with $119.9 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At June 30, 2017, the Company’s foreign subsidiaries had outstanding debt of $0.5 million.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Quimica Ltda., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:

1\. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 1.75 to 1.00, for the preceding four calendar quarters.

2\. The Restricted Group must maintain net worth of at least $325.0 million.

3\. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 60 percent.

4\. The Restricted Group may pay dividends and purchase treasury shares after December 31, 2013, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2014. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12 to the condensed consolidated financial statements.

The Company believes it was in compliance with all of its loan agreements as of June 30, 2017. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2017.

#### ENVIRONMENTAL AND LEGAL MATTERS

The Company’s operations are subject to extensive federal, state and local environmental laws and regulations and similar laws in the other countries in which the Company does business. Although the Company's environmental policies and practices are designed to address compliance with these laws and regulations, these policies and practices may not be effective, or future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company expects to continue to invest in the equipment and facilities necessary to comply with existing and future regulations. For the six months ended June 30, 2017 and 2016, the Company’s expenditures for capital projects related to the environment were $1.2 million and $0.7 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $13.0 million and $11.2 million for the six months ended June 30, 2017 and 2016, respectively.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $25.0 million to $45.8 million at June 30, 2017 compared to $25.7 million to $46.5 million at December 31, 2016. At June 30, 2017, and December 31, 2016, the Company's accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $25.0 million and $25.8 million, respectively. During the six-month period ended June 30, 2017, cash outlays related to legal and environmental matters approximated $1.0 million compared to $0.6 million for the same period in 2016.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

#### OUTLOOK

After achieving record first half net income, the Company remains optimistic about the balance of the year. The Company believes that its diversification efforts and enhanced internal efficiencies should continue to positively impact the remainder of 2017. The global rigid polyol market remains strong. Although competitive activity in North America will persist, the second half of the year should benefit from the partial recovery of higher raw material costs and lower manufacturing costs. Overall, management believes the Company earnings for the year should grow.

#### CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2016 Annual Report on Form 10-K.

#### RECONCILIATIONS OF NON-GAAP ADJUSTED NET INCOME AND EARNINGS PER SHARE

*(In millions, except per share amounts)*

|  | Three Months Ended June 30 2017 Net Income | Diluted EPS | 2016 Net Income | Diluted EPS |
| --- | ---: | ---: | ---: | ---: |
| **Net Income Attributable to the Company as Reported** | **$27.9** | **$1.19** | **$28.5** | **$1.24** |
| Deferred Compensation Expense (including related investment activity) | 4.1 | 0.17 | 2.3 | 0.10 |
| Business Restructuring | 0.6 | 0.03 | 1.1 | 0.04 |
| Cumulative Tax Effect on Above Adjustment Items | (1.7) | (0.07) | (1.2) | (0.05) |
| Adjusted Net Income | $30.9 | $1.32 | $30.7 | $1.33 |

*(In millions, except per share amounts)*

|  | Six Months Ended June 30 2017 Net Income | Diluted EPS | 2016 Net Income | Diluted EPS |
| --- | ---: | ---: | ---: | ---: |
| **Net Income Attributable to the Company as Reported** | **$59.8** | **$2.56** | **$56.4** | **$2.46** |
| Deferred Compensation Expense (including related investment activity) | 2.8 | 0.12 | 5.2 | 0.23 |
| Business Restructuring | 1.4 | 0.06 | 1.1 | 0.04 |
| Cumulative Tax Effect on Above Adjustment Items | (1.4) | (0.06) | (2.3) | (0.10) |
| Adjusted Net Income | $62.6 | $2.68 | $60.4 | $2.63 |

The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators. These measures should be considered in addition to, not a substitute for or superior to, measures of financial performance prepared in accordance with GAAP. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the noted transactions occurred.

#### RECONCILIATION OF NON-GAAP NET DEBT

*(In millions)*

|  | June 30, 2017 | December 31, 2016 |
| --- | ---: | ---: |
| Current Maturities of Long-Term Debt as Reported | $21.2 | $28.1 |
| Long-Term Debt as Reported | 283.2 | 288.9 |
| Total Debt as Reported | 304.4 | 317.0 |
| Less Cash and Cash Equivalents as Reported | (223.8) | (225.7) |
| Net Debt | $80.6 | $91.3 |

Management uses the non-GAAP net debt metric to gain a more complete picture of the Company’s overall liquidity, financial flexibility and leverage level. This adjusted measure should be considered supplemental to and not a substitute for financial information prepared in accordance with GAAP. The Company's definition of this adjusted measure may differ from similarly titled measures used by other entities.

## Controls and procedures

As filed, 1,278 characters.

a. Evaluation of Disclosure Controls and Procedures

We have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of June 30, 2017. Based on this evaluation of our disclosure controls and procedures, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of June 30, 2017, such that the information required to be disclosed in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Exchange Act and is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

b. Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal controls over financial reporting (as defined in Rule 13a-15(f) under Exchange Act) that occurred during the quarter ended June 30, 2017, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Jul 28, 2017.
Source: SEC EDGAR, the filing index for accession 0001564590-17-014350. Last ingested by Listed: Nov 10, 2026, 21:16 ET. No prices; not investment advice.
